
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf is experiencing anticipated growth in its Retail segment, particularly in Europe, with expected sequential and year-over-year sales increases in the third and fourth quarters. The company is on track to deliver significantly positive free cash flow (FCF), projected to nearly double to approximately $205 million by 2025. Additionally, Diebold Nixdorf's balance sheet and liquidity are reported to be in optimal condition, indicating a strong potential for further FCF conversion improvement.
Bears say
Diebold Nixdorf Inc faces several significant challenges that contribute to a negative outlook for its stock. Key risks include the company's potential inability to manage tariff-related costs effectively and disruptions in product shipments due to ongoing supply chain challenges, which could adversely affect operational efficiency. Additionally, lower than anticipated upgrade and replacement activity in the Banking segment, coupled with the volatility of currency exchange rates and a concerning liquidity situation characterized by low average daily trading volume, raises further concerns about the company's financial stability and growth prospects.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares